Next Article in Journal
Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation
Previous Article in Journal
Correction: Vaidyanathan et al. Are We Eating Our Way to Prostate Cancer—A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150. Non-Coding RNA 2016, 2, 2.
Article Menu

Export Article

Open AccessArticle
Non-Coding RNA 2016, 2(3), 7;

Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma

Laboratory of Molecular Cell Biology, Centre for Cancer Research and Department of Medicine C, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel
Functional Genomics Laboratory, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Institute of Oncology, Sheba Medical Center, Tel Hashomer 52621, Israel
Molecular Pathology Unit, Institute of Pathology University Hospital Basel, CH-4031 Basel, Switzerland
Recent Address Centre for Cancer Research, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel
Authors to whom correspondence should be addressed.
Academic Editor: George A. Calin
Received: 12 December 2015 / Revised: 13 June 2016 / Accepted: 19 June 2016 / Published: 30 June 2016
Full-Text   |   PDF [1509 KB, uploaded 4 July 2016]   |  


The threshold of 200 nucleotides (nt) conventionally divides non-coding RNAs (ncRNA) into long ncRNA (lincRNA, that have more than 200 nt in length) and the remaining ones which are grouped as “small” RNAs (microRNAs, small nucleolar RNAs and piwiRNAs). Promoter-associated RNAs (paRNAs) are generally 200–500 nt long and are transcribed from sequences positioned in the promoter regions of genes. Growing evidence suggests that paRNAs play a crucial role in controlling gene transcription. Here, we used deep sequencing to identify paRNA sequences that show altered expression in a melanoma cell line compared to normal melanocytes. Thousands of reads were mapped to transcription start site (TSS) regions. We limited our search to paRNAs adjacent to genes with an expression that differed between melanoma and normal melanocytes and a length of 200–500 nt that did not overlap the gene mRNA by more than 300 nt, ultimately leaving us with 11 such transcripts. Using quantitative real-time PCR (qRT-PCR), we found a significant correlation between the expression of the mRNA and its corresponding paRNA for two studied genes: TYR and HSPC152. Ectopic overexpression of the paRNA of HSPC152 (designated paHSPC) enhanced the expression of the HSPC152 mRNA, and an siRNA targeting the paHSPC152 decreased the expression of the HSPC152 mRNA. Overexpression of paHSPC also affected the epigenetic structure of its putative promoter region along with effects on several biologic features of melanoma cells. The ectopic expression of the paRNA to TYR did not have any effect. Overall, our work indicates that paRNAs may serve as an additional layer in the regulation of gene expression in melanoma, thus meriting further investigation. View Full-Text
Keywords: Promoter-Associated RNA; HSPC152; TYR; Melanoma Promoter-Associated RNA; HSPC152; TYR; Melanoma

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Bonen, H.; Kol, N.; Shomron, N.; Leibowitz-Amit, R.; Quagliata, L.; Lorber, T.; Sidi, Y.; Avni, D. Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma. Non-Coding RNA 2016, 2, 7.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Non-Coding RNA EISSN 2311-553X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top